ドキシサイクリンによるマラリア予防療法後のクロストリジウム・ディフィシル関連下痢

Clostridioides difficile colonization and infection in a cohort of Australian adults with cystic fibrosis.

The Journal of hospital infection·2021

Clostridium difficile and One Health.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019

In silico, in vitro and in vivo analysis of putative virulence factors identified in large clostridial toxin-negative, binary toxin- producing C. difficile strains.

Anaerobe·2019

Recurrence of Clostridium difficile infection in the Western Australian population.

Epidemiology and infection·2019

Status of vaccine research and development for Clostridium difficile.

Vaccine·2019

Natural products show diverse mechanisms of action against Clostridium difficile.

Journal of applied microbiology·2018

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

<i>Clostridioides difficile</i> Infection-Associated Functional Bowel Disorder: A Three-Year Cohort Study.

Open forum infectious diseases·2026

Dysphagia Aortica Secondary to a Giant Aortic Aneurysm: An Old Sign Revisited.

Cureus·2026

Liver Iron Content in Individuals With B-Thalassemia Trait and Hyperferritinemia: Role of Metabolic Alterations, <i>HFE</i> Genotypes, and Cirrhosis.

Mediterranean journal of hematology and infectious diseases·2026

Dietary Inflammatory Index and risk of nonalcoholic fatty liver disease: nonlinear associations, metabolic mediation, and external validation.

Frontiers in nutrition·2026

Association between vitamin D deficiency and longitudinal risk of head and neck cancer: a multi-institutional retrospective study.

Frontiers in nutrition·2026

Association between triglyceride-to-high-density lipoprotein cholesterol ratio and albuminuria in patients with type 2 diabetes: a cross-sectional study.

Frontiers in nutrition·2026

関連する実験動画

ドキシサイクリンによるマラリア予防療法後のクロストリジウム・ディフィシル関連下痢

関連する概念動画

Clostridioides difficile colonization and infection in a cohort of Australian adults with cystic fibrosis.

Clostridium difficile and One Health.

In silico, in vitro and in vivo analysis of putative virulence factors identified in large clostridial toxin-negative, binary toxin- producing C. difficile strains.

Recurrence of Clostridium difficile infection in the Western Australian population.

Status of vaccine research and development for Clostridium difficile.

Natural products show diverse mechanisms of action against Clostridium difficile.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

<i>Clostridioides difficile</i> Infection-Associated Functional Bowel Disorder: A Three-Year Cohort Study.

Dysphagia Aortica Secondary to a Giant Aortic Aneurysm: An Old Sign Revisited.

Liver Iron Content in Individuals With B-Thalassemia Trait and Hyperferritinemia: Role of Metabolic Alterations, <i>HFE</i> Genotypes, and Cirrhosis.

Dietary Inflammatory Index and risk of nonalcoholic fatty liver disease: nonlinear associations, metabolic mediation, and external validation.

Association between vitamin D deficiency and longitudinal risk of head and neck cancer: a multi-institutional retrospective study.

Association between triglyceride-to-high-density lipoprotein cholesterol ratio and albuminuria in patients with type 2 diabetes: a cross-sectional study.

関連する実験動画

ドキシサイクリンによるマラリア予防療法後のクロストリジウム・ディフィシル関連下痢

関連する概念動画

関連記事